TSC1 and lymphangioleiomyomatosis: This will also allow for the establishment of human cell lines that reflect TSC and LAM cell phenotypes and, following in vivo injection of TSC1/2-deficient cell lines, the generation of humanized animal models of LAM and TSC lesions.